Proteome Sciences appointed Martin Diggle to its board as a non-executive director. Diggle is a director and partner at Vulpes Investment Management, where he manages the Vulpes Life Sciences Fund, which holds roughly 16 percent of Proteome Sciences’ ordinary shares. He is also a non-executive director of Oxford Biomedica and Chronos Therapeutics.
People in the News: Martin Diggle
Oct 18, 2014